Indiva Shapes Strong Brand Identity in Canada, Eyes Emerging European Market -- CFN Media

SEATTLE, Feb. 06, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering INDIVA Limited (TSX-V:NDVA). Indiva is a licensed supplier of high quality, medical-grade cannabis located in London, Ontario; recognizing that many consumers are looking for alternatives to smoking, the company made a number of exciting strategic moves throughout 2018 to diversify its brand. The company went public in December of 2017, currently has $24 million on the balance sheet with a $46 million market cap, and its fully-funded facility expansion project is nearing completion.

Click here to see the company’s investor presentation

Indiva stresses quality over quantity, and intends to become a global brand recognized for high quality cannabis products and excellent client services. The INDIVA brand includes pre-rolls, capsules, and accessories, and the company has developed a range of other products in order to hit the ground running when Canada’s cannabis regulations are further liberalized later this year.

Indiva’s London facility includes four state of the art grow rooms and the $13.7 million, fully-funded, expansion currently underway will result in a 40,000 square foot facility with up to eight more rooms for cultivation, extraction, product manufacturing, and even a retail space. Indiva’s cannabis flower is produced using aeroponics, a soil-less process in which plant roots are suspended in air and misted with all the nutrients they need, producing larger yields and a much cleaner product while being environmentally friendly.

Bhang’s Award-Winning Offering

In April of 2018, the company announced a 50/50 joint venture with Nevada-based Bhang Corporation, an award-winning producer of cannabis and CBD edibles and concentrates, which will be managed by Indiva and enable the manufacture and sale of Bhang products in Canada, as well as the export of its products internationally. Through the agreement, Indiva gained exclusive access to Bhang’s portfolio of products including the most awarded line of chocolate bars in the world, gummies, oral sprays, isolates, vapes and vape cartridges, and a range of accessories. The company also announced a 4.9% stake in Bhang, giving it its first entry into the legal US adult-use market.

Click here to see the company’s investor presentation

“Flexible Edibles”

Later that same month, Indiva announced the company has a 14% stake in and exclusive license agreement with DeepCell Industries - a Seattle-based technology development company focusing on material science, microfluidics, and cannabinoid molecule discoveries – giving it the exclusive right to manufacture and market DeepCell’s entire line of innovative products produced through its patented Crystal Fusion technology. Crystal Fusion mechanically fuses cannabinoids with sugar or salt, producing a “flexible edible” with which consumers can infuse their food and beverages with flavour as well as THC or CBD. The resulting products are sold as Ruby Cannabis Sugar and Ruby Cannabis Salt.

All Bhang products and Ruby sugars and salts will be cross-branded in Canada - “Powered By INDIVA”.

MediPharm Extraction 

In September, Indiva entered into a Cannabis Concentrate Program Agreement with MediPharm Labs, Inc. a pioneer in the cannabis industry and the first Canadian licensed producer of cannabis oil under the Access to Cannabis for Medical Purposes Regulations. Indiva will supply dried cannabis to MediPharm, which it will use to produce cannabis oil. MediPharm may provide cannabis oil to Indiva or to other licensed producers at the direction of Indiva, which may release the cannabis extract for use by MediPharm. The program was established at no capital cost to Indiva, but MediPharm will charge the company processing fees for the oil produced, and the revenue on sales of oil by MediPharm will be shared between MediPharm and Indiva.

Click here to see the company’s investor presentation

Denmark, Gateway To European Cannabis Market

At the end of November, Indiva announced it had signed a non-binding letter of intent with AEssense Europe for the acquisition of 100% of a medical cannabis cultivation and handling license in Denmark. AEssense Europe received its license – one of only twelve granted - from the Danish Medicines Agency on January 12, 2018. The Danish Parliament legalized medical cannabis through a unanimous vote on January 1, 2018, and is poised to become one of Europe’s leading producers of medical cannabis. Denmark will serve as the company’s gateway to the European market, which is predicted to be larger than the US and Canadian markets combined.

Indiva will pursue the cultivation and worldwide distribution of EU-GMP certified medical cannabis and cannabis-derived products, and intends to incorporate a wholly-owned subsidiary, Indiva Europe, to finance and manage the European operations. In collaboration with AEssense, Indiva Europe plans to construct an indoor grow facility based on AEssense's proprietary AEtrium fully automated aeroponic grow platform, enabling Indiva to produce consistent, ultra-clean, premium pharmaceutical quality cannabis product compliant with GACP and EU-GMP standards. Sites have been identified to begin construction of a 1,000 square foot research lab as part of the production facility, with ample room for scaled expansion. Indiva will have the exclusive right to all cannabis-related production, and will leverage the Denmark license for the importation of EU-GMP cannabis into the Danish and European markets.

Community Engagement

Indiva is a community-minded company, helping first responders and veterans, chronic illness support organizations, and other community initiatives, and gives twenty cents from every gram of Indiva-branded flower and oil product to support mental and physical health initiatives and organizations across Canada. The company’s Master Grower, Pete Young, is well known for his cannabis activism, founded the London Compassion Society in the mid-90’s, and is a respected advocate of patients’ rights.

Indiva is worth watching as the company continues to diversify from a supplier of medical cannabis to a manufacturer and retailer of high margin cannabis-derived and pre-packaged products, partner with innovative companies like Bhang and Deepcell, and especially as its reach into larger foreign markets expands.

For more information, please visit:

Please follow the link to read the full article:

About CFN Media

For Visitors and Viewers

CFN Media’s Cannabis Financial Network ( is the destination for savvy investors and business people profiting from the worldwide cannabis industry. Viewers will see breaking news, exclusive content and original programming involving the people, companies and investments shaping the industry.

For Cannabis Businesses & Companies

CFN Media is a leading agency and financial media network dedicated to the cannabis industry. We help private, pre-public and public cannabis companies in the US and Canada attract capital, investors and media attention.

Our powerful digital media and distribution platform conveys a company’s message and value proposition directly to accredited and retail investors and national media active in the North American cannabis markets.

Since 2013, CFN Media has enabled the world’s preeminent cannabis companies to thrive in the capital and public markets.

Learn how to become a CFN Media client company, brand or entrepreneur:

Disclaimer is not an independent financial investment advisor or broker-dealer. You should always consult with your own independent legal, tax, and/or investment professionals before making any investment decisions. The information provided on (the ‘Site’) is either original financial news or paid advertisements drafted by our in-house team or provided by an affiliate., a financial news media and marketing firm enters into media buys or service agreements with the companies that are the subject of the articles posted on the Site or other editorials for advertising such companies.  We are not an independent news media provider. We make no warranty or representation about the information including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable. As such, your use of the information is at your own risk. Nor do we undertake any obligation to update the items posted. received compensation for producing and presenting high quality and sophisticated content on along with financial and corporate news.  

The above article is sponsored content. Emerging Growth LLC, which owns and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation


CFN Media

Frank Lane